/
Prediction of anti-diabetic activity of flavonoids targeting α-glucosidase Prediction of anti-diabetic activity of flavonoids targeting α-glucosidase

Prediction of anti-diabetic activity of flavonoids targeting α-glucosidase - PowerPoint Presentation

vivian
vivian . @vivian
Follow
342 views
Uploaded On 2022-06-07

Prediction of anti-diabetic activity of flavonoids targeting α-glucosidase - PPT Presentation

Marisa Freitas Adelaide Sousa Daniela Ribeiro Eduarda Fernandes Introduction Diabetes mellitus is a pandemic disease and is one of the main threats to human health Figure 1 Global projection for diabetes epidemic 20112030 ID: 914130

glucosidase flavonoids inhibition 200 flavonoids glucosidase 200 inhibition results µm introduction acarbose activity methods concentration sem competitive structures structure

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Prediction of anti-diabetic activity of ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Prediction of anti-diabetic activity of flavonoids targeting α-glucosidase

Marisa Freitas, Adelaide Sousa, Daniela Ribeiro, Eduarda Fernandes

Slide2

Introduction

Diabetes mellitus is a pandemic disease and is one of the main threats to human health.

Figure 1.

Global projection for diabetes epidemic: 2011-2030:

source

Reference: Ansari et al. 2015. International Journal of Diabetes Research 4(1): 7-12

Slide3

Introduction

GLUT4: Glucose

transporter

Pathophysiology

Adapted

from

: https

://www.pinterest.pt/pin/161707442848089173/

Slide4

Introduction

Source

: http

://www.giostar.com/Therapy/diabetes-type-2/

Hyperglicaemia

Slide5

Pharmacological treatment

Insulin

secretagogues

Biguanides

Thiazolidinediones

α

-

glucosidase

Sulfonylureas

Meglitidines

Tolbutamide

Chloroprapamide

Glyburide

Repaglinide

Metmorfin

Rosiglitazone

Acarbose

Miglitol

Introduction

Slide6

Introduction

Sucrase

-isomaltase

Maltase-glucoamylase

Glucose

Starch

α

-

amylase

Maltose

α

-

glucosidase

Slide7

Source

:

Adapted

from

http://www.servier.com/Powerpoint-image-bank

12

α

-

Glucosidase

Carbohydrates

Glicose

Acarbose

SGLT1

Intestinal

villy

Enterocyte

Without

acarbose

With

acarbose

α

-Glucosidase

Slide8

Side

effects

of

anti-diabetic

drugs

Flatulence

;

Abdominal

discomfort

;

Hepatic

disturbances

;

Contraindicated

in

patients

with

inflammatory diseasesIntroduction

Slide9

Introduction

Flavone

Isoflavone

Flavanone

Flavanol

Flavonol

Anthocyanin

Flavonoids

Slide10

12

Introduction

Inhibition

of

α

-

glucosidase

Biological

activities

of

flavonoids

Slide11

Introduction

a

Slide12

Introduction

a

Experimental

variables

Structure

activity

relationship

SAR

Slide13

AIM

a

1

2

3

Slide14

Methods

a

Chemical structures of the tested flavonoids

Slide15

Methods

a

Chemical structures of the tested flavonoids

Slide16

Methods

a

Inhibitor

Abs

. 405

nm

Slide17

Methods

a

Abs

= 405

nm

Optimization of the

microanalysis

tecnhique

DMSO

Phosphate

buffer, pH=6.8

α-

glucosidase

from

Saccharomyces

cerevisiae

(0 – 0.4 U/mL)

5 min, 37˚C

pNPG

(150 – 2400 µM)

40 - 60 min, 37˚C

Slide18

R

esults

a

Variation

of

α-

glucosidase

concentration

pNPG

= 600

µM

Slide19

R

esults

a

Variation

of

substrate

concentration

α

-

glucosidase

= 0.050 U/

mL

Slide20

Methods

a

Abs

= 405

nm

Study

of

the

inhibitory

activity

of

a

panel

of

flavonoids

Flavonoids

/

Acarbose

/DMSO

Phosphate

buffer, pH=6.8

α-

glucosidase

from

Saccharomyces

cerevisiae

(0.05

U/

mL

)

5 min, 37˚C

pNPG

(600 µM)

30 min, 37˚C

Slide21

Results

a

Compound

Structure

R

2’

R

3

R

3’

R

4’

R

6

R

7

R

8

IC

50

(μM)

A1

(

Flavone

)

-

H

H

H

-

-

-

<20%*

200

μM

a

A2

-

H

OH

H

-

-

-

<20%*

200

μM

aA3-HHOH---<20%* 200 μM aA4-HOHOH---32 ± 4%* 200 μM aA5-OHOHOH---54 ± 3A6-OHOMeOMe---<20%* 100 μM aB1--HH---<20%* 200 μM aB2--OHH---31 ± 4%* 200 μM aB3--HOH---66 ± 2B4--OHOH---66 ± 7a - Inhibitory activity (mean ± SEM %) at the highest tested concentration (in superscript).Table 1. Structures and in vitro α-glucosidase inhibition by the studied flavonoids (IC50 µM, mean ± SEM).

Slide22

Results

Compound

Structure

R

2’

R

3

R

3’

R

4’

R

6

R

7

R

8

IC

50

(μM)

C1

-

H

H

H

-

OH

H

<20%*

200 μM a

C2

-

H

OH

H

-

OH

H

53 ± 4

C3

-

H

H

OH

-

OH

H

≈ 200C4-OHOHH-OHH42 ± 4C5-OHHOH-OHH96 ± 10C6-HOHOH-OHH95 ± 7C7-OHOHOH-OHOH7.6 ± 0.4C8-OHOMeH-OMeH22 ± 2%* 100 μM aC9-OHHOMe-OMeH<20%* 200 μM aC10-OHOHOH-OMeOMe86 ± 6C11-OHOMeOMe-OHOH31 ± 3%* 200 μM aC12-OHOBnOBn-OMeOMe<20%* 200 μM aC13-OHOMeOMe-OBnOBn32 ± 3%* 200 μM aTable 1. Structures and in vitro α-glucosidase inhibition by the studied flavonoids (IC50 µM, mean ± SEM).a - Inhibitory activity (mean ± SEM %) at the highest tested concentration (in superscript).

Slide23

Results

a

Compound

Structure

R

2’

R

3

R

3’

R

4’

R

6

R

7

R

8

IC

50

(μM)

D1

(

Chrysin

)

H

H

H

H

H

-

H

<20%*

50 μM a

D2

(Galangin)

H

OH

H

H

H

-

H

21 ± 3%*

200

μM

aD3(Baicalein)H

HHHOH-H44 ± 3D4HHOHHH-H89 ± 3D5(Apigenin)HHHOHH-H82 ± 6D6(Kaempferol)HOHHOHH-H32 ± 3D7(Luteolin)HHOHOHH-H46 ± 6D8 (Quercetin)HOHOHOHH-H15 ± 3D9(Morin)OHOHHOHH-H32 ± 2Table 1. Structures and in vitro α-glucosidase inhibition by the studied flavonoids (IC50 µM, mean ± SEM).

Slide24

Results

a

Compound

Structure

R

2’

R

3

R

3’

R

4’

R

6

R

7

R

8

IC

50

(

μM

)

E1

(Naringenin)

-

H

H

-

-

-

-

45 ± 3%*

200 μM a

E2

(Eriodictyol)

-

H

OH

-

-

-

-

35 ± 4%*

200 μM a

E3

(Taxifolin)

-OHOH----≈200Positive control:Acarbose-------607 ± 56Table 1. Structures and in vitro α-glucosidase inhibition by the studied flavonoids (IC50 µM, mean ± SEM).a - Inhibitory activity (mean ± SEM %) at the highest tested concentration (in superscript).

Slide25

Results

a

A5

C7

D8 (

quercetin

)

The

most

active

flavonoids

:

Slide26

Results

a

Molecular

docking

calculations

Slide27

Methods

a

Inhibition

type

of

the

most

active

flavonoids

Enzyme

: 0.05 U/

mL

pNPG

:

300, 600 e 1200

µM

Michaelis-

Menten

Equation

:

Lineweaver-Burk

Equation

:

 

Slide28

Methods

a

Inhibition

type

of

the

most

active

flavonoids

Slide29

Results

a

Mixed

Inhibition

Slide30

Results

a

Competitive

Inhibition

Slide31

Results

a

Non-

Competitive

Inhibition

Slide32

Results

a

Flavonoid

Type of Inhibition

Ki (μM)

A5

Mixed

41.0

B3

Mixed

127.0

C7

Competitive

6.5

D8 (quercetin)

Competitive

6.8

E3 (taxifolin)

Non-competitive

347.1

Positive control:

Acarbose

Competitive

457.3

Table 2.

Ki values

(

lM

) for the inhibition of yeast a-glucosidase by the

selected

flavonoids

.

Slide33

Conclusions

a

A

microanalysis

tecnhique

was

implemented

for

the

evaluationof

the

inhibitory

effect

of

flavonoids

against

α

-

glucosidase

.

Enzyme

concentration

: 0.050 U/

mL

Substrate

concentration

: 600 µM

Kinetic

time: 30

minutes

The

substitution

pattern of flavonoids significatively affects their inhibitory activity. The flavonoid structure, the position and number of OH groups are determinant factors for the intended effect.

Slide34

a

Slide35

Aknowlgements

a